{"id":5671,"date":"2017-08-19T20:10:26","date_gmt":"2017-08-20T00:10:26","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/actos-lawsuit\/"},"modified":"2022-06-21T16:54:07","modified_gmt":"2022-06-21T20:54:07","slug":"pozew-sadowy","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/teren-do-cwiczen-2\/pozew-sadowy\/","title":{"rendered":"Actos Lawsuit"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">NIE PRZYJMUJEMY JU\u017b SPRAW ACTOS<\/h2>\n<h3><\/h3>\n<h3>Z\u0142o\u017cenie pozwu Actos za obra\u017cenia spowodowane przez Actos (pioglitazon)<\/h3>\n<p>Actos (pioglitazone) is a treatment for type 2 diabetes. Available only by prescription, pioglitazone is in a class of medications called thiazolidinediones. Thiazolidinediones work in the body to balance the blood sugar by increasing the cells\u2019 receptiveness to insulin. Patients may have taken this drug under the brand name Actos or under other names such as Actoplus Met (pioglitazone and metformin) or Duetact (pioglitazone and glimepiride). People experiencing adverse side effects have begun filing actos lawsuits.<\/p>\n<p>More than two million Americans with type 2 diabetes take Actos. Many are increasingly concerned (and rightfully so) about potential side effects. Actos is the most prescribed medication for the treatment of type 2 diabetes, generating 3.4 billion in sales in 2009. However, recent studies have shown a link between this medication and bladder cancer. Some users are therefore considering their legal options in filing an Actos lawsuit against the manufacturer, Takeda Pharmaceuticals. With the serious side effects they have experienced, recovering financial compensation can make a significant difference in their ability to pay for medical care, lost earnings and other financial, physical and emotional losses or injuries.<\/p>\n<p>&nbsp;<\/p>\n<h3>Powa\u017cne skutki uboczne zwi\u0105zane z Actos<\/h3>\n<p>People taking this medication for treatment of type 2 diabetes should be aware that they are at risk for developing serious side effects, including new or worsening heart failure and liver problems. The government has also warned of pioglitazone and bladder cancer risks.<\/p>\n<p>The U.S. Food and Drug Administration (FDA) issued a warning in September of 2010 about Actos and bladder cancer after reviewing data from a ten-year study conducted by Takeda Pharmaceutical Company, the drug manufacturer. Data showed a link between Actos and bladder cancer. People taking the highest doses of the drug, or who had taken the drug for a long time, were at the highest risk of developing bladder cancer. Many of those victims have filed an Actos lawsuit.<\/p>\n<p><strong>Opr\u00f3cz raka p\u0119cherza Actos mo\u017ce stwarza\u0107 dodatkowe ryzyko, kt\u00f3re mo\u017ce by\u0107 szkodliwe, trwa\u0142e lub zagra\u017caj\u0105ce \u017cyciu.<\/strong><\/p>\n<ul>\n<li><strong>Ryzyko z\u0142amania ko\u015bci \u2013 <\/strong>Actos mo\u017ce dwukrotnie lub wi\u0119cej razy zwi\u0119ksza\u0107 ryzyko z\u0142ama\u0144 ko\u015bci. Wykazano, \u017ce ryzyko jest wi\u0119ksze u kobiet, ale mo\u017ce dotyczy\u0107 m\u0119\u017cczyzn i wyst\u0119puje g\u0142\u00f3wnie w ramionach, podudziach lub biodrach i jest prawdopodobnie zwi\u0105zane z wp\u0142ywem leku Actos na wzrost tkanki kostnej.<\/li>\n<li><strong>Zastoinowa niewydolno\u015b\u0107 serca \u2013 <\/strong>Actos mo\u017ce podwoi\u0107 ryzyko wyst\u0105pienia niewydolno\u015bci serca. Pocz\u0105wszy od 1 2007 r. FDA wymaga\u0142a dodania \u201eostrze\u017cenia o czarnej skrzynce\u201d do informacji dla Actos o ryzyku zastoinowej niewydolno\u015bci serca.<\/li>\n<li><strong>Przewlek\u0142\u0105 chorob\u0119 nerek -<\/strong> Przyjmowanie Actosu mo\u017ce zwi\u0119kszy\u0107 ryzyko choroby nerek nawet o 400 procent. Choroba nerek powoduje wysokie ci\u015bnienie krwi, pogarsza problemy z sercem i mo\u017ce skutkowa\u0107 konieczno\u015bci\u0105 wymiany nerki lub schy\u0142kow\u0105 niewydolno\u015bci\u0105 nerek (ESRD), kt\u00f3ra mo\u017ce spowodowa\u0107 \u015bmier\u0107.<\/li>\n<li><strong>obrz\u0119k plamki \u2013 <\/strong>Obrz\u0119k plamki mo\u017ce spowodowa\u0107 uszkodzenie siatk\u00f3wki i trwa\u0142\u0105 \u015blepot\u0119. Ryzyko obrz\u0119ku plamki \u017c\u00f3\u0142tej jest wi\u0119ksze u pacjent\u00f3w z cukrzyc\u0105. Badanie z 2009 roku wykaza\u0142o, \u017ce lek podwaja ryzyko rozwoju obrz\u0119ku plamki \u017c\u00f3\u0142tej i \u015blepoty.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Kiedy w czerwcu 2011 r. wyniki badania Actos przeprowadzonego przez rz\u0105d francuski r\u00f3wnie\u017c wykaza\u0142y zwi\u0105zek mi\u0119dzy Actos a rakiem p\u0119cherza moczowego, organy regulacyjne we Francji i Niemczech wycofa\u0142y Actos, wycofuj\u0105c lek z rynku. W odpowiedzi FDA za\u017c\u0105da\u0142a zmiany w etykiecie skutk\u00f3w ubocznych Actos, aby ostrzec ludzi przyjmuj\u0105cych lek na cukrzyc\u0119 typu 2 o ryzyku. FDA nie wyda\u0142a wycofania Actos w USA<\/p>\n<p>&nbsp;<\/p>\n<h3>Niebezpieczne objawy<\/h3>\n<p>Before the labeling change, patients taking Actos may not have known about or understood the link between Actos and bladder cancer, and this is why many are pursuing an Actos lawsuit. They may have even experienced potential symptoms of bladder cancer without realizing what they were or that they could have been linked to Actos use.<\/p>\n<p>Inform your doctor immediately if you took Actos for your type 2 diabetes and are experiencing such symptoms as:<\/p>\n<div class=\"two-col\">\n<ul>\n<li>Krew w moczu<\/li>\n<li>Parcie na mocz<\/li>\n<li>B\u00f3l podczas oddawania moczu<\/li>\n<li>B\u00f3l plec\u00f3w lub brzucha<\/li>\n<li>Nowa lub gorsza niewydolno\u015b\u0107 serca;<\/li>\n<li>Obrz\u0119k;<\/li>\n<li>problemy z w\u0105trob\u0105;<\/li>\n<li>Rak p\u0119cherza;<\/li>\n<li>hipoglikemia;<\/li>\n<li>Z\u0142amane ko\u015bci\/z\u0142amania;<\/li>\n<li>obrz\u0119k plamki \u017c\u00f3\u0142tej; I<\/li>\n<li>Owulacja prowadz\u0105ca do ci\u0105\u017cy.<\/li>\n<\/ul>\n<\/div>\n<p>&nbsp;<\/p>\n<h3>Pozwy Actos \u2013 co musisz wiedzie\u0107<\/h3>\n<p>Victims of harm caused as a direct result of taking Actos have the right to take legal action against Takeda Pharmaceuticals. An Actos lawsuit may seek damages based on Takeda\u2019s negligence. These Actos lawsuits allege that Takeda failed to properly warn of the risks of taking Actos, continued to manufacture and market the drug despite known risks, manufactured a defective product, failed to properly test Actos, or\/and did not reveal Actos testing data to the public.<\/p>\n<p>There are class action lawsuits currently pending against Actos\u2019 manufacturer. You may have the right to join an existing Actos lawsuit, or file a civil action independently.<\/p>\n<p>Working with an Actos attorney will ensure that you have the information to properly present your case for damages in the Actos litigation.<\/p>\n<p>&nbsp;<\/p>\n<h3>Skontaktuj si\u0119 z naszym biurem, aby uzyska\u0107 bezp\u0142atn\u0105 analiz\u0119 sprawy<\/h3>\n<p>Je\u015bli przyjmowa\u0142e\u015b pioglitazon w leczeniu cukrzycy typu 2, a lekarz p\u00f3\u017aniej zdiagnozowa\u0142 u ciebie raka p\u0119cherza moczowego, mo\u017cesz mie\u0107 pow\u00f3d do z\u0142o\u017cenia pozwu przeciwko rakowi p\u0119cherza moczowego Actos. Firma farmaceutyczna mog\u0142a nie ostrzec Ci\u0119 odpowiednio o zwi\u0105zku mi\u0119dzy Actos a rakiem p\u0119cherza moczowego. By\u0107 mo\u017ce \u017ale przepisano Ci ten lek. A <a href=\"\/pl\/teren-do-cwiczen-2\/spory-farmaceutyczne\/\">spory farmaceutyczne<\/a> prawnik w Napoli Shkolnik, PLLC mo\u017ce zapewni\u0107 bezp\u0142atn\u0105 konsultacj\u0119 prawn\u0105, aby pozna\u0107 Twoje prawa. Nasi prawnicy pomogli tysi\u0105com os\u00f3b poszkodowanych przez wadliwe leki na recept\u0119. Chcemy reprezentowa\u0107 Ci\u0119 w Twoim pozwie Actos. Nie boimy si\u0119 podj\u0105\u0107 walki z firm\u0105 farmaceutyczn\u0105 o to, co dla Ciebie wa\u017cne, o sprawiedliwo\u015b\u0107 i odszkodowanie. Aby dowiedzie\u0107 si\u0119 wi\u0119cej o swoim prawie do podj\u0119cia dzia\u0142a\u0144 prawnych, zadzwo\u0144 do nas ju\u017c dzi\u015b, aby um\u00f3wi\u0107 si\u0119 na konsultacj\u0119 w sprawie.<\/p>","protected":false},"excerpt":{"rendered":"<p>WE ARE NO LONGER ACCEPTING ACTOS CASES Filing an Actos Lawsuit for Injuries Caused by Actos (Pioglitazone) Actos (pioglitazone) is a treatment for type 2 diabetes. Available only by prescription,&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":49,"template":"","practiceareas_category":[743],"class_list":["post-5671","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5671\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=5671"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas_category?post=5671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}